Literature DB >> 26622716

Soluble purified recombinant C2ORF40 protein inhibits esophageal cancer cell proliferation by inducing cell cycle G1 phase block.

Xiaoyan Li1, Linwei Li1, Wenyu Wang1, Yang Yang2, Yun Zhou1, Shixin Lu2.   

Abstract

Chromosome 2 open reading frame 40 (C2ORF40) plays a significant role in numerous processes, including cell differentiation, senescence, apoptosis, inflammation and neuroendocrine hormone regulation. Moreover, C2ORF40 is a candidate tumor suppressor gene in a variety of tumors, and is closely associated with prognosis. Bioinformatics analysis has indicated that pro-C2ORF40 is a secreted protein with a signal peptide. Secreted C2ORF40 protein (sC2ORF40) exists in cancer cell medium. However, thus far, the exact biological function of sC2ORF40 in carcinogenesis has not been thoroughly researched. In the present study, the signal peptide sequence of the C2ORF40 complementary DNA was initially cut off to produce secreted recombinant human C2ORF40 protein (rhC2ORF40). The soluble rhC2ORF40 was expressed, purified and examined for tumor-suppressing function for the first time. The results revealed that the soluble purified rhC2ORF40 protein was concentrated with a purity of >95%. Furthermore, the rhC2ORF40 inhibited esophageal cancer cell proliferation in vitro (P<0.05) and caused cell cycle G1 phase block, as determined by flow cytometric analysis (P<0.05). Overall, the soluble rhC2ORF40 protein with high purity and biological activity was obtained, which suppressed esophageal cancer cells proliferation by inducing cell cycle G1 phase block in vitro. Therefore, the soluble rhC2ORF40 protein could be potential biological therapy drug for esophageal carcinoma.

Entities:  

Keywords:  biological therapy; cell proliferation; purification; rhC2ORF40

Year:  2015        PMID: 26622716      PMCID: PMC4533669          DOI: 10.3892/ol.2015.3429

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  18 in total

1.  Enhanced expression of the human chitinase 3-like 2 gene (YKL-39) but not chitinase 3-like 1 gene (YKL-40) in osteoarthritic cartilage.

Authors:  Eric Steck; Stephen Breit; Steffen J Breusch; Matthias Axt; Wiltrud Richter
Journal:  Biochem Biophys Res Commun       Date:  2002-11-22       Impact factor: 3.575

2.  Esophageal cancer related gene 4 (ECRG4) is a marker of articular chondrocyte differentiation and cartilage destruction.

Authors:  Yun Hyun Huh; Je-Hwang Ryu; Sun Shin; Dong-Uk Lee; Siyoung Yang; Kyung-Shin Oh; Churl-Hong Chun; Jeong-Keun Choi; Woo Keun Song; Jang-Soo Chun
Journal:  Gene       Date:  2009-09-06       Impact factor: 3.688

3.  ECRG4 is a negative regulator of caspase-8-mediated apoptosis in human T-leukemia cells.

Authors:  Junichi Matsuzaki; Toshihiko Torigoe; Yoshihiko Hirohashi; Kenjiro Kamiguchi; Yasuaki Tamura; Tomohide Tsukahara; Terufumi Kubo; Akari Takahashi; Emiri Nakazawa; Eri Saka; Kazuyo Yasuda; Shuji Takahashi; Noriyuki Sato
Journal:  Carcinogenesis       Date:  2012-03-12       Impact factor: 4.944

4.  Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells.

Authors:  Yuki Kujuro; Norihiro Suzuki; Toru Kondo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

5.  ECRG1, a novel candidate of tumor suppressor gene in the esophageal carcinoma, triggers a senescent program in NIH3T3 cells.

Authors:  Nianxi Zhao; Ge Huang; Liping Guo; Shih-Hsin Lu
Journal:  Exp Biol Med (Maywood)       Date:  2006-01

6.  C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes.

Authors:  Jing Lu; Mingxin Wen; Yurong Huang; Xiuquan He; Yunshan Wang; Qi Wu; Zengchun Li; Andres Castellanos-Martin; Mar Abad; Juan J Cruz-Hernandez; Cesar A Rodriguez; Jesús Pérez-Losada; Jian-Hua Mao; Guangwei Wei
Journal:  Epigenetics       Date:  2013-04-26       Impact factor: 4.528

7.  Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Authors:  Yoichiro Mori; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Horoki Kurehara; Ryota Mori; Keisuke Tomoda; Ryo Ogawa; Takeyasu Katada; Koshiro Harata; Yoshitaka Fujii
Journal:  Oncol Rep       Date:  2007-10       Impact factor: 3.906

8.  Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo.

Authors:  Lin-Wei Li; Xi-Ying Yu; Yang Yang; Chun-Peng Zhang; Li-Ping Guo; Shih-Hsin Lu
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

9.  The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma.

Authors:  Linwei Li; Chunpeng Zhang; Xiaoyan Li; ShihHsin Lu; Yun Zhou
Journal:  J Exp Clin Cancer Res       Date:  2010-10-11

10.  ECRG4 inhibits growth and invasiveness of squamous cell carcinoma of the head and neck in vitro and in vivo.

Authors:  Ting Xu; Dajiang Xiao; Xin Zhang
Journal:  Oncol Lett       Date:  2013-04-10       Impact factor: 2.967

View more
  4 in total

1.  C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.

Authors:  Zuozhong Xie; Wei Li; Jingang Ai; Jun Xie; Xiaowei Zhang
Journal:  J Transl Med       Date:  2022-06-08       Impact factor: 8.440

2.  Soluble purified recombinant C2ORF40 protein inhibits tumor cell growth in vivo by decreasing telomerase activity in esophageal squamous cell carcinoma.

Authors:  Linwei Li; Xiaoyan Li; Wenyu Wang; Tianhui Gao; Yun Zhou; Shixin Lu
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

3.  Identification of Differentially Expressed Genes Induced by Aberrant Methylation in Oral Squamous Cell Carcinomas Using Integrated Bioinformatic Analysis.

Authors:  Xiaoqi Zhang; Hao Feng; Dongfang Li; Shanshan Liu; Norio Amizuka; Minqi Li
Journal:  Int J Mol Sci       Date:  2018-06-07       Impact factor: 5.923

4.  A Systematic Investigation of the Malignant Functions and Diagnostic Potential of the Cancer Secretome.

Authors:  Jonathan L Robinson; Amir Feizi; Mathias Uhlén; Jens Nielsen
Journal:  Cell Rep       Date:  2019-03-05       Impact factor: 9.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.